|
Acusphere licences HDDS(TM) to Cephalon |
|
|
|
|
News -
Nanomedicine and Drug Delivery News Archive
|
|
Monday, 31 March 2008 |
|
Acusphere announced that it entered into an agreement to license its Hydrophobic Drug Delivery System(TM) (HDDS) for oncology applications, as well as its product AI-850 to Cephalon for $10 million.
HDDS(TM) converts water insoluble drugs into microparticles or nanoparticles of the drug embedded in small microspheres, such that the drug can more rapidly dissolve in water.
AI-850(TM) is the initial product candidate utilizing Acusphere’s HDDS(TM) technology, and it is a readily dissolving formulation of paclitaxel.
Source: Acusphere, Inc.; Cephalon, Inc. |
